Water → HCID 10449723, compound
Reaction equation
[N:1]1([S:7]([C:10]2[C:18]3[C:13](=[CH:14][CH:15]=[C:16]([CH:19]=C)[CH:17]=3)[NH:12][C:11]=2[C:21]([NH2:23])=[O:22])(=[O:9])=[O:8])[CH2:6][CH2:5][O:4][CH2:3][CH2:2]1.I([O-])(=O)(=O)=[O:25].[Na+].O.C([O-])(O)=O.[Na+]>CC(C)=O.[Os](=O)(=O)(=O)=O>[CH:19]([C:16]1[CH:17]=[C:18]2[C:13](=[CH:14][CH:15]=1)[NH:12][C:11]([C:21]([NH2:23])=[O:22])=[C:10]2[S:7]([N:1]1[CH2:2][CH2:3][O:4][CH2:5][CH2:6]1)(=[O:8])=[O:9])=[O:25]Participants
7
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
3-(Morpholin-4-ylsulfonyl)-5-vinyl-1H-indole-2-carboxamide (207 mg, 0.617 mmol, 1.0 equiv), sodium periodate (660 mg, 3.09 mmol, 5.0 equiv) and osmium tetraoxide (16 mg, 0.062 mmol, 0.1 equiv) were dissolved in 18 mL of a 5:1 solution of acetone:water and stirred for 18 hours. The mixture was poured into aqueous saturated NaHCO3 and extracted three times with dichloromethane. The combined organic extracts were dried (Na2SO4), filtered and concentrated in vacuo. The title compound was obtained by preparative reversed phase HPLC. Proton NMR for the product was consistent with the titled compound. ESI+MS: 338.1 [M+H]+.
Workup
- extractionextracted three times with dichloromethane
- dry with materialThe combined organic extracts were dried (Na2SO4)
- filtrationfiltered
- concentrationconcentrated in vacuo
Sources & evidence
- ORD record
- ord-1396c0bf2aec4d08901fc69f9e7238ea
- Source dataset
- uspto-grants-2009_07
- Patent number
- US07560546B2
Reaction notes
Loading…